I completed my PhD on the “Genetics of familial breast cancer” at the Imperial Cancer Research Fund, with genetic studies to identify the two breast cancer genes, BRCA1 and BRCA2, and their importance in familial and sporadic breast cancer. This study resulted in first author papers in the Lancet and Human Molecular Genetics. In addition, I collaborated with Professor Irene Leigh at the Royal London Hospital, to perform genetic studies on familial palmoplantar keratodermas, particularly the localization of a predisposition gene to both skin disease and oesophageal cancer. After a short but successful Wellcome Trust postdoctoral, I joined SmithKline Beecham (now GlaxoSmithKline) where I used a bioinformatic approach to identify new molecular targets. From there I returned to academia and the Centre for Cutaneous Research as a Senior Lecturer to work on human skin genetics and keratinocyte biology. I was made Professor of Human Molecular Genetics in September 2003. I am Deputy Director of Research at the Blizard Institute and board member of the European Society of Dermatological Research. I have been a trustee of Cure EB since registration.

“As an academic researcher working on other genetic skin and related disorders I am really impressed with the vision, enthusiasm and focus into translating therapies to this specific condition. I am delighted to help support Cure EB in this important mission”